We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Latest Round of Conflict Waivers Seen as Illustrating Flaws in FDA Policy
Latest Round of Conflict Waivers Seen as Illustrating Flaws in FDA Policy
November 28, 2006
The FDA’s decision to grant conflict of interest waivers for two-thirds of the voting members of an advisory committee proves that the agency is not following Congress’ or the Institute of Medicine’s (IOM) directives to minimize such conflicts, sources say.